CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. The company is headquartered in Brentwood, Tennessee and currently employs 1,090 full-time employees. The company went IPO on 2015-07-24. The firm supports biopharmaceutical companies, contract manufacturers (CDMOs), contract research organizations (CROs), developers, and researchers with a comprehensive suite of services and products. Its integrated supply chain platform includes the Cryoportal Logistics Management Platform, advanced temperature-controlled packaging, informatics, specialized biologistics, biostorage, bioservices, and cryogenic systems. The firm's segments include Life Sciences Services and Life Sciences Products. The firm's Life Sciences Services segment provides cryogenic biostorage within the life science industry through direct sales. Its Life Sciences Products segment manufactures and sells cryogenic freezers, cryogenic dewars and accessories within the life science industry through direct sales or a distribution network.
Follow-Up Questions
Cryoport Inc의 CEO는 누구입니까?
Mr. Jerrell Shelton은 2012부터 회사에 합류한 Cryoport Inc의 Chairman of the Board입니다.
CYRX 주식의 가격 성능은 어떻습니까?
CYRX의 현재 가격은 $9.98이며, 전 거래일에 increased 0.15% 하였습니다.
Cryoport Inc의 주요 사업 주제나 업종은 무엇입니까?
Cryoport Inc은 Life Sciences Tools & Services 업종에 속하며, 해당 부문은 Health Care입니다
Cryoport Inc의 시가총액은 얼마입니까?
Cryoport Inc의 현재 시가총액은 $499.9M입니다
Cryoport Inc는 매수, 매도, 아니면 보유해야 하나요?
월스트리트 분석가들에 따르면, 11명의 분석가가 Cryoport Inc에 대한 분석 평가를 실시했으며, 이는 6명의 강력한 매수, 7명의 매수, 2명의 보유, 0명의 매도, 그리고 6명의 강력한 매도를 포함합니다
